Unfolded Protein Response Is Required in nu/nu Mice Microvasculature for Treating Breast Tumor with Tunicamycin
Open Access
- 1 August 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (33), 29127-29138
- https://doi.org/10.1074/jbc.m110.169771
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?Cancer Research, 2009
- Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapyThe Breast, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Lineage Infidelity of MDA-MB-435 CellsCancer Research, 2004
- The Hallmarks of CancerCell, 2000
- The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthNature, 1994
- A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesisNature, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Functional and morphological changes induced by tunicamycin in dividing and confluent endothelial cellsExperimental Cell Research, 1992
- Role of extracellular signaling on endothelial cell proliferation and protein N‐glycosylationJournal of Cellular Physiology, 1990